Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TH 0318

Drug Profile

TH 0318

Alternative Names: Glucagon-like peptide-1 analogues - Theratechnologies; TH0318; ThGLP-1

Latest Information Update: 01 Oct 2007

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ALZA Corporation; Theratechnologies
  • Class
  • Mechanism of Action Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 26 Sep 2007 GLP-1 portfolio of compounds licensed to OctoPlus worldwide for the treatment of diabetes and other potential indications
  • 02 Oct 2006 TH 0318 is still available for out-licensing (http://www.theratech.com)
  • 15 Mar 2006 TH 0318 is available for out-licensing (http://www.theratech.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top